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Background: In the Wnt pathway, the secreted frizzled-related protein 2 (SFRP2) is thought to act as one of the
several competitive inhibitors of Wnt. However, the precise role of SFRP2 is still poorly understood especially in B
lymphocytes. Here, we investigated the function of SFRP2, comparing the SFRP2 defective as well as normal B
lymphocytes in mice.
Results: We demonstrated that calcium influx from extracellular to intracellular space in splenic B cells was clearly
affected by the defect of SFRP2. In addition, the phosphorylation of phospholipase Cγ2 was observed to be reduced in
SFRP2 defective splenic B cells with B cell receptor stimulation.
Conclusions: SFRP2 is suggested to modulate the influx from extracellular calcium in the B cell receptor signaling pathway.
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The Wnt pathway is one of the important signal mech-
anisms related to cell differentiation in embryogenesis,
hematopoiesis, and carcinogenesis [1]. It is mainly divided
into three categories as Wnt/β-catenin, Wnt/planar cell
polarity, and Wnt/calcium pathway [2-5]. In particular, the
Wnt/β-catenin pathway, which also termed as “canonical
pathway”, has been investigated extensively and well
understood, comparing to other pathways termed as
“noncanonical pathway” [6,7].
The Wnt protein is one of the extracellular ligands
binding to the family of Frizzled receptors associated
with several receptor-related proteins. Also, the Wnt
pathways are regulated with activators or inhibitors [8].
Especially, the secreted frizzled-related protein 2 (SFRP2)
(also known as SDF5 [9]) is a competitive inhibitor to act
as antagonist of the Wnt pathway [10,11].
During embryogenesis, where Wnt signaling is in-
volved, the defect of Sfrp2 causes brachysyndactyly in
mice [12]. Our previous research also showed that the
dysfunction of SFRP2 protein yields a phenotype of
preaxial synpolydactyly and syndactyly [13]. Moreover,* Correspondence: tashiro@koto.kpu-m.ac.jp
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unless otherwise stated.SFRP2 has reported to be hypermethylated in the prostate
cancer [14], gastric cancer [15], and colorectal cancer [16],
and to suppress bone formation in multiple myeloma cells
[17]. On the other hand, the Wnt is known to maintain
hematopoietic stem cells (HSCs) in the bone marrow
(BM) niche under the both canonical [18] and noncano-
nical pathways [6], and various Wnt antagonists such as
SFRP2 are suggested to play a role in the regulation of
HSCs. In the Wnt pathways of hematopoiesis, SFRP2 as
secreted protein is suggested to inhibit the Wnt pathway
and maintain the quiescent of HSCs in mice [19]. SFRP2
is also known to be expressed in osteoblasts in BM and
related to the proliferation of HSCs [20]. However, the
function of SFRP2 on immune system is still unclear, espe-
cially in the calcium signaling of B lymphocytes.
Here, we demonstrated that SFRP2 modulates the cal-
cium signal transduction associated with activation cascade
in downstream of B cell receptor (BCR) signaling pathway.
Methods
Mice
Mice of wild-type (Sfrp2+/+) C57BL/6 and of Sfrp2-de-
fective strains (Sfrp2-/-) were bred under the specific
pathogen-free (SPF) conditions as described in our pre-
vious study [13]. In this study, all mice were examined
at 10-12 weeks of age. Reproducibility of data was
confirmed by repeating each experiment at least moreLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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mouse experiments followed the guidelines and were
approved by the Kyoto Prefectural University of Medicine
Animal Care and Use Committee.
Cell preparation
The cell suspensions were obtained from the BM and
spleen samples. After the elimination of red blood cells,
the cells in the BM or spleen were suspended in phos-
phate buffered saline (PBS) with 3% fetal bovine serum.
For the western blotting, the splenic B cells were purified
by negative isolation using Dynabeads® Mouse CD43 (Un-
touched™ B Cells) (Invitrogen, Carlsbad, CA, USA) accord-
ing to the manufacturer’s protocol.
Cell differentiation analysis
BM cells were stained by the monoclonal antibodies
against the surface markers as follows: FITC-conjugated
anti-IgM (II/41), anti-CD43 (S7) and APC-conjugated
anti-CD45R/B220 (RA3-6B2; anti-B220). Splenocytes
were similarly stained by the monoclonal antibodies
as follows: FITC-conjugated anti-CD21/CD35 (7G6),
PE-Cy7-conjugated anti-IgM (R6–60.2), anti-B220 anti-
body (BD Pharmingen, San Diego, CA, USA) and PE-
conjugated anti-CD23 (B3B4) antibody (eBioscience,
San Diego, CA, USA). All flow cytometry (FACS) ex-
periments were performed by BD FACS Canto II and
BD FACSDiva software version 6.1.3 (BD Biosciences,
San Jose, CA, USA) according to the manufacturer’s
protocol. The analysis was performed using the FlowJo
software (Tree Star, San Carlos, CA, USA).
Calcium influx analysis
Cell suspensions of splenocytes were incubated at 37°C
for 45 min with Fluo 4-AM (Fluo4; Dojindo, Kumamoto,
Japan) and Fura Red™ AM (Fura Red; Invitrogen), which
final concentrations were 3 μM and 6 μM, respectively.
After stained with anti-B220, the cells were resuspended
in calcium-free Hank’s balanced salt solution (HBSS/Ca−).
Intracellular calcium levels were assessed by the ratio of
the intensities of Fluo4/Fura Red [21], which the ratios
were averaged for every 10 sec. In the experiments, anti-
mouse IgM F(ab’)2 fragments (anti-IgM; final concentra-
tion 10 μg/ml in HBSS/Ca−, Jackson Immunoresearch,
West Grove, PA, USA) and ethylene glycol bis(2-ami-
noethyl)-N,N,N’,N’-tetraacetic acid (EGTA; final concen-
tration 0.5 mM in HBSS/Ca−), and calcium (Ca; CaCl2
final concentration 1.26 mM in HBSS/Ca−) were applied.
These experiments were replicated at least three times.
Endoplasmic reticulum (ER) analysis
The splenocytes were incubated at 37°C in 5% CO2 for
45 min in PBS (Mg+, Ca+) and 1 μM ER-Tracker™ Green
dye (glibenclamide BODIPY® FL, ER-Tracker; MolecularProbes, Invitrogen) to evaluate the ER abundance [22].
After staining with anti-B220 for 10 min, the cells were
resuspended in PBS (Mg+, Ca+) for FACS analysis.
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
RT-PCR experiments were performed with Multiple Tissue
cDNA (MTC) panels of Mouse (Clontech Laboratories,
CA, USA) and Sfrp2+/+ and Sfrp2-/- samples, which were
from only Sfrp2+/+ and both mouse for SFRP2 and
β-catenin tests, respectively. The cDNAs from Sfrp2+/+
and Sfrp2-/- mouse samples were synthesized in 20 μl
products with 200 ng total RNA from splenic B and BM
cells and Super Script II (Invitrogen) according to the
manufacturer’s protocol. In the PCR process, each cDNA
in appropriate mixture was amplified with each specific
primer pair, and their details were described in Additional
files 1 and 2.
Protein phosphorylation assay by FACS
The phosphorylation assay of proteins was measured by
FACS with BD™ Phosflow technology (BD Biosciences)
according to the manufacturer’s instructions. The stimula-
tions for splenic B cells were examined by anti-IgM anti-
body (final concentration 10 μg/ml; Jackson Immuno
research) or lipopolysaccharide (LPS, final concentra-
tion 20 μg/ml; Sigma-Aldrich, San Francisco, CA, USA)
in time course of 0, 5, 10, and 15 min. In the case of
IgM stimulation, the antibody set of Alexa Fluor® 488
Mouse ERK1/2 (pT202/pY204) (Erk1/2) and PE Mouse
anti-Syk (pY348) (Syk) was applied to detect the phos-
phorylated proteins. In the case of LPS stimulation,
Erk1/2 and PE Mouse p38 MAPK (pT180/pY182) (P38)
(BD™ Phosflow, BD Biosciences) were examined. These
antibodies with anti-B220 were stained for splenic B
cells for 30 min in Phosflow experiment process.
Western blotting
The purified splenic B cells were stimulated by anti-IgM
(10 μg/ml, Jackson) in HBSS with calcium. The samples
were evaluated by antibodies from Antibody Sampler Kits
(Cell Signaling Technology, Inc. (CST), Danvers, MA,
USA) as follows: anti-phospho-Syk (Tyr525/526), anti-Syk,
anti-phospho-Lyn (Tyr507), anti-Lyn, anti-phospho-Btk
(Tyr223), anti-Btk, anti-phospho-CD19 (Tyr531), and
anti-CD19 from B Cell Signaling Antibody Sampler Kit;
anti-phospho-PLCγ2 (Tyr1217), anti-phospho-PLCγ2
(Tyr759), and anti-PLCγ2 antibody from PLCγ Anti-
body Sampler Kit; anti-phospho-SAPK/JNK (Thr183/
Tyr185), and anti-phospho-ATF-2 (Thr71) from Phospho-
SAPK/JNK Pathway Antibody Sampler Kit. Moreover,
anti-NFAT1, anti-NFAT2, and β-actin antibody (CST)
were also applied. These antibodies were detected with
anti-rabbit IgG-HRP (CST) as secondary antibody. The
signals were detected with the ECL Prime or ECL Plus
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UK Ltd., Buckinghamshire, UK) according to the man-
ufacturer’s protocol. In addition, the Can Get Signal
Immunoreaction Enhancer Solution (Toyobo Co., Ltd,
Osaka, Japan) was applied if necessary. The results of
western blots were analyzed by ImageJ software (http://
imagej.nih.gov/ij/index.html).Figure 1 Comparison of BM and splenic B cell differentiation. The cell
representative FACS plots are demonstrated by FlowJo. (A) The results of B
B (IMB), and mature B (MB) cells. The histograms indicate the means and SD
statistical significant difference between Sfrp2+/+ and Sfrp2-/- in these cell
cells for transitional type 1 (T1), marginal zone B (MZB), transitional type 2
the means and SD of the 6 gender-matched littermates. In splenic B cells,
Sfrp2-/- by Student’s t-tests.Statistical analysis
In order to prepare the FACS data for statistical analysis,
Office Excel and Visual C++ (Microsoft, Redmond,
Washington, USA) were used. We employed R software
(http://www.R-project.org/) to perform the statistical
analysis including t–test in each FACS data and draw
the graphs. In the histograms, error bars indicate standards in the BM or spleen were assessed with each surface marker. The
M are indicated for B cell differentiation stages of pro-B, pre-B, immature
of the 6 littermates with same gender pairs for these cell stages. No
stages was observed by Student’s t-tests. (B) The results of splenic B
(T2), and follicular B (FOB) cells are indicated. The histograms indicate
there was no statistical significant difference between Sfrp2+/+ and
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tRankTests” was used for Wilcoxon tests.Results
Cell differentiation
In order to evaluate the differences in B cell differenti-
ation, BM and splenic B cells obtained from Sfrp2+/+ and
Sfrp2-/- mice were assessed by FACS analysis. No change
in B cell differentiation was observed between Sfrp2+/+
and Sfrp2-/- mice by the statistical analysis (Figure 1).Calcium influx
The differences of calcium signal transduction between
Sfrp2+/+ and Sfrp2-/- splenic B cells were evaluated by
FACS. No significant difference of intracellular calcium
levels was observed with anti-IgM stimulation under the
calcium free condition (open arrows in Figure 2). After
the addition of extracellular calcium (dotted arrows in
Figure 2), intracellular calcium levels rapidly increased
because of the influx of extracellular calcium after
anti-IgM stimulation. Once reaching the peak, intra-
cellular calcium levels were then gradually decreased withFigure 2 Calcium influx of splenic B cell. The calcium influx in splenic B
were derived from 3 littermates with same gender pair and assessed after
circles (Sfrp2+/+) and red squares (Sfrp2-/-). The black asterisks indicate the s
regions indicate the differences of intensity ratios between Sfrp2+/+ and Sfr
were stimulated with anti-IgM (IgM; open arrow). Furthermore, the cells we
similar process, the cells were then incubated with EGTA at 7 min (filled arthe statistical significant difference between Sfrp2+/+ and
Sfrp2-/- splenic B cells (Figure 2A). However, the differ-
ence of intracellular calcium levels between Sfrp2+/+ and
Sfrp2-/- splenic B cells rapidly disappeared after the re-
moval of extracellular calcium by EGTA (filled arrow in
Figure 2B).ER abundance analysis
ER abundance in splenic B cells was evaluated with ER-
Tracker. The results showed that there was no statistical
significant difference for ER abundance between the Sfrp2+/+
and Sfrp2-/- splenic B cells (Figure 3).SFRP2 and β-catenin expression
The expression of SFRP2 studied by RT-PCR was high
in BM, but very low in spleen/splenic B cells (Additional
file 1). On the other hand, the expression of β-catenin
was clearly noted in spleen similar to other tissues, as
well as in Sfrp2+/+ and Sfrp2-/- splenocytes (Additional
file 2A and B). However, phosphorylated β-catenin was
barely detectable in BM or spleen tissues by Western
blotting (Additional file 2C).cells was examined by FACS. The Sfrp2+/+ and Sfrp2-/- splenic B cells
gated with anti-B220. The means of 3 replicates are plotted by the blue
tatistical significance by paired t-test in each time point. Blue shaded
p2-/- splenic B cells. (A) After 1.5 min acquisition of signals, the cells
re treated with calcium at 3 min (dotted arrow). (B) Following the
row).
Figure 3 ER abundance of splenic B cell. (A) The representative
results of ER abundance in splenic B cells gated with anti-B220 are
displayed by using FlowJo. Upper (blue) and lower (red) plots are
represented as the percentages of the max of the ER-Tracker signals
in splenic B cell of Sfrp2+/+ and Sfrp2-/-, respectively. The filled areas
indicate ER-Tracker stained B cells and the line areas indicate the in-
tensity of non-stained samples. (B) The histograms indicate the means
and SD of the 4 littermate pairs for the percentage of ER-Tracker posi-
tive cells. No statistical significant difference in ER abundance between
Sfrp2+/+ and Sfrp2-/- splenic B cells was observed by Student’s t-tests.
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Before western blots analysis, we first tested each phos-
phorylation of Erk1/2, P38, and Syk in Sfrp2+/+ and Sfrp2-/-
splenic B cells with use of FACS (Additional file 3). Results
showed that there was no significant phosphorylation
difference between Sfrp2+/+ and Sfrp2-/- when stimu-
lated with either IgM or LPS. Therefore, we examined
phosphorylation status of the proteins involved in the
BCR signaling pathway with use of western blotting for
purified splenic B cells. The purity of splenic B cells was
about 98.6% in lymphocytes confirmed by FACS ana-
lysis (data not shown).
The phosphorylation of Syk, Lyn, Btk, CD19, and
PLCγ2, which is the important downstream effectors of
BCR signaling pathway, were assessed comparing with
the total amount of each protein. In the western blot
analysis, no difference between Sfrp2+/+ and Sfrp2-/- splenic
B cells was observed in the time-course experiments after
BCR stimulation with anti-IgM (0, 1, 5, 20, and 60 min)
(Figure 4A). However, in the Tyr1217 site of PLCγ2, the
signals of Sfrp2-/- splenic B cells decreased after 5 min
stimulation compared with Sfrp2+/+ samples (Figure 4B).
By contrast, no significant difference was observed in
the phosphorylation of PLCγ2 at Tyr759 in this study.
Accordingly, the defect of Sfrp2 was considered to affect
the phosphorylation of PLCγ2 at Tyr1217 but not Tyr759
in the BCR signaling pathway.
In addition, NFAT1 and NFAT2 were investigated as
downstream components of PLCγ2 in the BCR signaling
(Figure 4C). Because there was no difference in these pro-
teins between Sfrp2+/+ and Sfrp2-/-, the defect of Sfrp2 was
considered not to play a role in the downstream of PLCγ2.
Also, in the downstream of calcium signaling cascade
related to BCR signaling pathway, no significant differ-
ence of phosphorylation in JNK and ATF-2 was found
between Sfrp2+/+ and Sfrp2-/- splenic B cells (Figure 4D).
Discussion
In this study, we investigated B lymphocytes in mice
affected by the defect of Sfrp2, and this defect did not yield
the remarkable influence on the early differentiation of B
cells (Figure 1). Therefore, we further examined mature B
cells in spleen about the influence of the defect of Sfrp2 in
intracellular signal transduction in detail.
Figure 4 (See legend on next page.)
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Figure 4 Western blotting results of PLCγ2 splenic B cell. The representative results of western blotting were displayed. Splenic B cells were
stimulated with anti-IgM. All experiments were replicated and confirmed three times at least. “n” indicates the number of total tested sample for
each protein. (A) The phosphorylation of Syk (Tyr525/526; pSyk), Lyn (Tyr507; pLyn), Btk (Tyr223; pBtk), and CD19 (Tyr531; pCD19) sites and (B)
Tyr1217 and Tyr759 phosphorylation of PLCγ2 were demonstrated with “Total” as the controls, which indicate the amount of each applied protein.
(C) The expressions of NFAT1 and NFAT2 were indicated with β-actin. (D) The phosphorylation of SAPK/JNK (Thr183/Tyr185; pJNK) and ATF-2 (Thr71;
pATF-2) were indicated with β-actin. Note that there were two bands for JNK in 54 and 46 kDa due to isoforms as noted by arrows. The ratio of expres-
sion level of each sample was calculated by using ImageJ.
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mune system including B cells [23], and so the calcium in-
flux for splenic B cells with Sfrp2 defect was selectively
examined. We showed that the calcium signal transduc-
tion by BCR activation was slightly increased in Sfrp2+/+
as well as Sfrp2-/- splenic B cells under calcium free
condition (open arrows in Figure 2). Moreover, no dif-
ference of ER abundance was observed between these B
cells (Figure 3). Thus, we could conclude that no signifi-
cant difference was observed in the intracellular calcium
store in both Sfrp2+/+and Sfrp2-/- splenic B cells. How-
ever, when the calcium was added in the extracellular
space (dotted arrows in Figure 2), intracellular calcium
levels were rapidly increased in both Sfrp2+/+ and
Sfrp2-/- splenic B cells due to the influx of extracellular
calcium by the BCR stimulation. This was considered to
be attributed to the activation of calcium release-
activated calcium channel in the plasma membrane trig-
gered by emptying of ER calcium stores under calcium
free condition and the first IgM stimulation (open arrows
in Figure 2) [23]. Subsequently, intracellular calcium levels
gradually decreased and differed significantly between
Sfrp2+/+ and Sfrp2-/- splenic B cells (Figure 2A). By con-
trast, intracellular calcium levels were rapidly decreased to
the same levels in both splenic B cells after EGTA addition
(Figure 2B). Therefore, this phenomenon was observed as
a result of the difference of the calcium influx from extra-
cellular to intracellular space between Sfrp2+/+ and Sfrp2-/-
splenic B cells.
This calcium influx phenomenon is known to be asso-
ciated with the activation of several proteins involved in
the regulation of cell homeostasis. Specifically, protein
tyrosine kinases such as Syk and Lyn are initially acti-
vated in response to BCR stimulation, which leads to the
activation of Btk and CD19. PLCγ2 is then activated by
Btk, and cleaves phosphatidylinositol-bisphosphate (PIP2)
into diacylglycerol and inositol (1, 4, 5)-trisphosphate (IP3)
by hydrolysis. Subsequently, IP3 induced calcium release
from intracellular ER calcium stores by binding to the IP3
receptor. The catalytic hydrolysis of PIP2 is suggested to
require the phosphorylation of Tyr759 in PLCγ2 [24,25].
Moreover, the role of Tyr759 phosphorylation is con-
sidered to be different from that of Tyr1217 in PLCγ2
according to the types of cells or stimulations [26]. Our
results clearly showed that the defect of Sfrp2 does notaffect the phosphorylation of Syk, Lyn, Btk, and CD19,
but reduces the phosphorylation of PLCγ2 at Tyr1217,
whereas Tyr759 phosphorylation remained unaffected
(Figure 4B). This result may indicate that the Sfrp2
participates in not pivotally regulating the catalytic
hydrolysis of PIP2 but modulating the calcium signal
transduction.
It was unknown if the effect of these defective Sfrp2 on
PLCγ2 is correlated with other abnormal mechanisms in
the canonical and/or non-canonical pathways. First, since
SFRP2 is not expressed in the hematopoietic cells, espe-
cially in splenic B cells compared to BM cells in Sfrp2+/+
mice (Additional file 1), exogenous SFRP2 provided from
other tissues may contribute to the calcium signaling in the
splenic B cell. Moreover, since β-catenin is rarely detectable
as protein levels in these splenic B cells (Additional file 2),
exogenous SFRP2 may act on the calcium signaling through
non-canonical pathway. However, NFAT1, NFAT2, JNK,
and ATF-2, which are considered as members of a cascade
in downstream of non-canonical signaling pathway, were
found not to play a significant role in the Sfrp2-/- splenic B
cells (Figure 4C and D). Taken together, the dysregulation
of calcium signaling in the Sfrp2-/- splenic B cells occurs
under BCR stimulation and is likely to be correlated with
unknown common underlying signal pathway(s) of both
BCR and non-canonical signalings.
As previously reported, the expression of SFRP2 was
down-regulated by methylation in cancer [14,15]. Because
calcium signaling was reduced by defect of Sfrp2, down-
regulation of SFRP2 is assumed to impair the calcium
signal transduction in each tissue or cell. However the im-
mune dysfunction was not observed in our SFRP2 deficient
mice under the SPF condition, it was reported the asso-
ciation between the methylation of SFRP2 and cancer
[14-17]. Although further examination is needed, our
results might give us the new insights to understand
the functions of SFRP2 under the BCR and calcium signal
pathway and the mechanisms of several human diseases.Conclusions
The defect of Sfrp2 in mice splenic B cells causes the im-
pairment of calcium influx and the activation of PLCγ2 in
the BCR signaling pathway. This phenomenon is speculated
to be indirectly related to the activations of Wnt pathways.
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